182 related articles for article (PubMed ID: 21836060)
1. Honokiol radiosensitizes colorectal cancer cells: enhanced activity in cells with mismatch repair defects.
He Z; Subramaniam D; Ramalingam S; Dhar A; Postier RG; Umar S; Zhang Y; Anant S
Am J Physiol Gastrointest Liver Physiol; 2011 Nov; 301(5):G929-37. PubMed ID: 21836060
[TBL] [Abstract][Full Text] [Related]
2. Expression of survivin and p53 modulates honokiol-induced apoptosis in colorectal cancer cells.
Lai YJ; Lin CI; Wang CL; Chao JI
J Cell Biochem; 2014 Nov; 115(11):1888-99. PubMed ID: 24905183
[TBL] [Abstract][Full Text] [Related]
3. Enhanced radiosensitization with gemcitabine in mismatch repair-deficient HCT116 cells.
Robinson BW; Im MM; Ljungman M; Praz F; Shewach DS
Cancer Res; 2003 Oct; 63(20):6935-41. PubMed ID: 14583494
[TBL] [Abstract][Full Text] [Related]
4. Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity.
Hahm ER; Singh SV
Mol Cancer Ther; 2007 Oct; 6(10):2686-95. PubMed ID: 17938262
[TBL] [Abstract][Full Text] [Related]
5. Radiosensitization of NSCLC cells to X-rays and carbon ions by the CHK1/CHK2 inhibitor AZD7762, Honokiol and Tunicamycin.
Liu B; Chen W; Li H; Li F; Jin X; Li Q
Radiat Environ Biophys; 2020 Nov; 59(4):723-732. PubMed ID: 32857208
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells.
Park EJ; Min HY; Chung HJ; Hong JY; Kang YJ; Hung TM; Youn UJ; Kim YS; Bae K; Kang SS; Lee SK
Cancer Lett; 2009 May; 277(2):133-40. PubMed ID: 19135778
[TBL] [Abstract][Full Text] [Related]
7. Honokiol in combination with radiation targets notch signaling to inhibit colon cancer stem cells.
Ponnurangam S; Mammen JM; Ramalingam S; He Z; Zhang Y; Umar S; Subramaniam D; Anant S
Mol Cancer Ther; 2012 Apr; 11(4):963-72. PubMed ID: 22319203
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of p53-mutant human colorectal cancer cells radiosensitivity by flavonoid fisetin.
Chen WS; Lee YJ; Yu YC; Hsaio CH; Yen JH; Yu SH; Tsai YJ; Chiu SJ
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1527-35. PubMed ID: 20637980
[TBL] [Abstract][Full Text] [Related]
9. Effect of H(2)O(2) on cell cycle and survival in DNA mismatch repair-deficient and -proficient cell lines.
Chang DK; Goel A; Ricciardiello L; Lee DH; Chang CL; Carethers JM; Boland CR
Cancer Lett; 2003 Jun; 195(2):243-51. PubMed ID: 12767533
[TBL] [Abstract][Full Text] [Related]
10. Honokiol induces cell cycle arrest and apoptosis via inhibition of survival signals in adult T-cell leukemia.
Ishikawa C; Arbiser JL; Mori N
Biochim Biophys Acta; 2012 Jul; 1820(7):879-87. PubMed ID: 22465179
[TBL] [Abstract][Full Text] [Related]
11. Honokiol Radiosensitizes Squamous Cell Carcinoma of the Head and Neck by Downregulation of Survivin.
Wang X; Beitler JJ; Huang W; Chen G; Qian G; Magliocca K; Patel MR; Chen AY; Zhang J; Nannapaneni S; Kim S; Chen Z; Deng X; Saba NF; Chen ZG; Arbiser JL; Shin DM
Clin Cancer Res; 2018 Feb; 24(4):858-869. PubMed ID: 29180609
[No Abstract] [Full Text] [Related]
12. In vitro growth inhibition of human cancer cells by novel honokiol analogs.
Lin JM; Prakasha Gowda AS; Sharma AK; Amin S
Bioorg Med Chem; 2012 May; 20(10):3202-11. PubMed ID: 22533983
[TBL] [Abstract][Full Text] [Related]
13. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.
Huang KJ; Kuo CH; Chen SH; Lin CY; Lee YR
J Cell Mol Med; 2018 Mar; 22(3):1894-1908. PubMed ID: 29363886
[TBL] [Abstract][Full Text] [Related]
14. Honokiol induces cytotoxic and cytostatic effects in malignant melanoma cancer cells.
Kaushik G; Ramalingam S; Subramaniam D; Rangarajan P; Protti P; Rammamoorthy P; Anant S; Mammen JM
Am J Surg; 2012 Dec; 204(6):868-73. PubMed ID: 23231930
[TBL] [Abstract][Full Text] [Related]
15. Combined effect of honokiol and rosiglitazone on cell growth inhibition through enhanced G0/G1 phase arrest in hepatoma cells.
Chen HC; Hsu HT; Weng JW; Chang YF; Hsia CY; Lee HC; Chi CW
J Chin Med Assoc; 2016 Aug; 79(8):415-21. PubMed ID: 27094504
[TBL] [Abstract][Full Text] [Related]
16. Metformin Radiosensitizes p53-Deficient Colorectal Cancer Cells through Induction of G2/M Arrest and Inhibition of DNA Repair Proteins.
Jeong YK; Kim MS; Lee JY; Kim EH; Ha H
PLoS One; 2015; 10(11):e0143596. PubMed ID: 26599019
[TBL] [Abstract][Full Text] [Related]
17. Honokiol: a potent chemotherapy candidate for human colorectal carcinoma.
Chen F; Wang T; Wu YF; Gu Y; Xu XL; Zheng S; Hu X
World J Gastroenterol; 2004 Dec; 10(23):3459-63. PubMed ID: 15526365
[TBL] [Abstract][Full Text] [Related]
18. Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors.
Leeman-Neill RJ; Cai Q; Joyce SC; Thomas SM; Bhola NE; Neill DB; Arbiser JL; Grandis JR
Clin Cancer Res; 2010 May; 16(9):2571-9. PubMed ID: 20388852
[TBL] [Abstract][Full Text] [Related]
19. DNA damage signaling in response to 5-fluorouracil in three colorectal cancer cell lines with different mismatch repair and TP53 status.
Adamsen BL; Kravik KL; De Angelis PM
Int J Oncol; 2011 Sep; 39(3):673-82. PubMed ID: 21674128
[TBL] [Abstract][Full Text] [Related]
20. Honokiol, a potential therapeutic agent, induces cell cycle arrest and program cell death in vitro and in vivo in human thyroid cancer cells.
Lu CH; Chen SH; Chang YS; Liu YW; Wu JY; Lim YP; Yu HI; Lee YR
Pharmacol Res; 2017 Jan; 115():288-298. PubMed ID: 27940017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
